No Longer Enrolling

Clinical TrialStudy Result Published
A4 Study
3-year prevention trial

2-year study of cardiovascular influences on AD

Atomoxetine Clinical Trial:
for people with Mild Cognitive Impairment (MCI)

Neuroimaging & Biomarkers Study - ADNI: Normal Aging, Mild Cognitive Impairment & Early Alzheimer's Disease

Over 100 Study publications

Racial Disparities in ADL's

Results pending

Registry for Remembrance
An initiative to increase awareness & participation in neurology research

DIAN Study
2-year prevention trial

Right Frontal Activity in Older Adults: Does it Help or Hurt Word Retrieval?

Effects of Perceptual Interference on Memory in Mild Cognitive Impairment (MCI)

The Tele-Savvy Program
A 6 week on-line education & training program for persons caring for a family member with Alzheimer's disease or other dementia.

Alzheimer's Disease Neuroimaging Initiative - GO
Pre-Mild Cognitive Impariment Study

A 18 month infusion study to slow Alzheimer's disease (AD) progression

A clinical trial testing a new treatment for Alzheimer's disease (AD)

Nerve Growth Factor: Gene Therapy Surgical Intervention Trial

Results pending.

Lewy Body Disease

Cognitive Rehabilitation of Memory in Mild Cognitive Impairment
Examines changes in learning, memory, and brain activity

Cognitive Aging Project

Natural History of FTD Subtypes

Memory Training in Mild Cognitive Impairment

Results pending


2-year trial for treatment of MCI

DHA, an Omega 3 Fatty Acide, in Slowing the Progression of Alzheimer's DiseaseDocosahexaenoic acid supplementation and cognitive decline in Alzheimer disease: a randomized trial

RAGE (Receptor for Advanced Glycation Endproducts) Inhibitor StudyPF-04494700, an Oral Inhibitor of Receptor for Advanced Glycation End Products (RAGE), in Alzheimer Disease

Caregiver Opportunities for Optimizing Lifestyles: A Research Opportunity for African American Caregivers (COOL-AD)

Development of a Biomarker for FTLD-TDP and FTLD-Tau

Cognitive Decline in Patients with Amyotrophic Lateral Sclerosis (ALS)

Agitation/Psychosis in Dementia/Parkinsonism (TAP/DAP)Quetiapine for agitation or psychosis in patients with dementia and parkinsonism.
Kurlan R, Cummings J, Raman R, Thal L for the Alzheimer's Disease Cooperative Study Group Neurology. 2007 April 24: 68; 1356-1363

Vitamins to Slow Alzheimer's Disease (Homocysteine Study) (VITAL)High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: a randomized controlled trial

Mild Cognitive Impairment Study Aricept, Vitamin E or PlaceboVitamin E and donepezil for the treatment of mild cognitive impairment.
Petersen RC, Thomas RG, Grundman M, Bennett D, Doody R, Ferris S, Galasko D, Jin S, Kaye J, Levey A, Pfeiffer E, Sano M, van Dyck CH, Thal LJ; Alzheimer's Disease Cooperative Study Group, N Engl J Med. 2005 Jun 9; 352(23):2379-88. Epub 2005 Apr 13

1 year study for treatment of bvFTD

The Role of Sleep in Cognitive Decline in Normal Aging

5-year prevention trial

VASCULAR studies the role of circulatory function on memory and the risk of Alzheimer┬┐s disease.